Overview

Pharmacokinetic Study of Oral ALXN1840 in Japanese and Non-Japanese Adult Healthy Participants

Status:
Completed
Trial end date:
2019-05-02
Target enrollment:
Participant gender:
Summary
The main purpose of the study is to confirm how long ALXN1840 stays in the body of Japanese and non-Japanese healthy participants (that is, pharmacokinetic [PK] profile).
Phase:
Phase 1
Details
Lead Sponsor:
Alexion Pharmaceuticals